scholarly journals High Expression of Class III β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer

2013 ◽  
Vol 13 (2) ◽  
pp. 103-108 ◽  
Author(s):  
Yihong Wang ◽  
Joseph A. Sparano ◽  
Susan Fineberg ◽  
Lesley Stead ◽  
Jaya Sunkara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
High Expression ◽  
Class Iii ◽  
Estrogen Receptor Negative ◽  
Β Tubulin

scholarly journals High expression of soluble CD155 in estrogen receptor-negative breast cancer

Breast Cancer ◽  
2019 ◽  
Vol 27 (1) ◽  
pp. 92-99 ◽  
Author(s):  
Akiko Iguchi-Manaka ◽  
Genki Okumura ◽  
Emika Ichioka ◽  
Hiroko Kiyomatsu ◽  
Tatsuhiko Ikeda ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
High Expression ◽  
Estrogen Receptor Negative

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer

2005 ◽  
Vol 97 (3) ◽  
pp. 245-254 ◽  
Author(s):  
James J. Dignam ◽  
Kelly Wieand ◽  
Karen A. Johnson ◽  
Peter Raich ◽  
Stewart J. Anderson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Lymph Node ◽  
Node Negative ◽  
Estrogen Receptor Negative

scholarly journals Targeting Aberrant p70S6K Activation for Estrogen Receptor–Negative Breast Cancer Prevention

2017 ◽  
Vol 10 (11) ◽  
pp. 641-650 ◽  
Author(s):  
Xiao Wang ◽  
Jun Yao ◽  
Jinyang Wang ◽  
Qingling Zhang ◽  
Samuel W. Brady ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Prevention ◽  
Breast Cancer Prevention ◽  
Estrogen Receptor Negative ◽  
P70s6k Activation
Sign in / Sign up

Export Citation Format

Share Document